A few words from Valérie Lorentz-Poinsot

Because people worldwide are increasingly refusing to take risks with their health, Laboratoires BOIRON uses its unique pharmaceutical expertise in homeopathy to bring them the safe medicines they need.

Some things never change. Laboratoires BOIRON has been the world leader in homeopathy for many years. Our business has always been driven by the growing demand among both patients and healthcare providers for the effective, safe, and gentle treatments offered by homeopathy.

Even so, 2018 was a turning point for our business. In 2018, we updated our industrial organization to better meet customer demand by concentrating all our production teams on the Messimy site and developing the Les Olmes logistics platform to secure our distribution. We also faced extremely high demand in the United States and Asia, which at times put our logistics chain under pressure. 2018 also saw e-commerce come into its own as a viable sales channel that makes our medicines freely and easily available to the public, particularly in our new regions.

As we look to the future, we can enter 2019 firm in our assurance that:

• Our teams and their well-being will always remain a core concern;

• Our organization will continue to grow and change, especially in France, due to the steady decline in prescriptions for compounded preparations;

• We must further increase our agility in production to manage increasingly urgent and differentiated requests;

• We must continue our research in homeopathy and ensure that its objectives are in line with the needs of the business, regulatory agencies, and healthcare professionals.

And as it has been since the beginning, the global development of homeopathy remains our ultimate goal.

Valérie Lorentz-Poinsot
General Manager


Code Euroclear : 6112
Isin : FR0000061129

Bloomberg : BOI FP
Reuters : BOIR.PA
Datastream : F:BOIR